Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday
Benzinga·5d ago
Share
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Needham cut ON Semiconductor Corporation (NASDAQ:ON) price target from $57 to $50. Needham analyst Quinn Bolton maintained a Buy rating. ON Semiconductor shares closed at $38.41 on Monday. See how other analysts view this stock.
Compass Point slashed the price target for MARA Holdings, Inc. (NASDAQ:MARA) from $25 to $9.5. Compass Point analyst Joe Flynn downgraded the stock from Neutral to Sell. MARA Holdings shares closed at $13.09 on Monday. See how other analysts view this stock.
Leerink Partners cut Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) price target from $550 to $503. Leerink Partners analyst David Risinger downgraded the stock from Outperform to Market Perform. Vertex Pharmaceuticals shares closed at $500.19 on Monday. See how other analysts view this stock.
HC Wainwright & Co. raised the price target for Solaris Resources Inc. (NYSE:SLSR) from $10 to $11. HC Wainwright & Co. analyst Heiko Ihle maintained a Buy rating. Solaris Resources shares closed at $4.33 on Monday. See how other analysts view this stock.
Telsey Advisory Group slashed the price target for Ethan Allen Interiors Inc. (NYSE:ETD) from $32 to $30. Telsey Advisory Group analyst Cristina Fernandez maintained a Market Perform rating. Ethan Allen Interiors shares closed at $29.13 on Monday. See how other analysts view this stock.
Rosenblatt raised Fabrinet (NYSE:FN) price target from $230 to $250. Rosenblatt analyst Mike Genovese maintained a Buy rating. Fabrinet shares settled at $220.90 on Monday. See how other analysts view this stock.
Telsey Advisory Group cut NIKE, Inc (NYSE:NKE) price target from $80 to $70. Telsey Advisory Group analyst Cristina Fernandez maintained a Market Perform rating. Nike shares closed at $57.35 on Monday. See how other analysts view this stock.
Canaccord Genuity cut Castle Biosciences, Inc. (NASDAQ:CSTL) price target from $42 to $37. Canaccord Genuity analyst Kyle Mikson maintained a Buy rating. Castle Biosciences shares closed at $18.75 on Monday. See how other analysts view this stock.
JP Morgan cut the price target for Twist Bioscience Corporation (NASDAQ:TWST) from $40 to $33. JP Morgan analyst Rachel Vatnsdal maintained an Underweight rating. Twist Bioscience shares settled at $35.93 on Monday. See how other analysts view this stock.
JP Morgan raised Quest Diagnostics Incorporated (NYSE:DGX) price target from $180 to $190. JP Morgan analyst Lisa Gill maintained a Neutral rating. Quest Diagnostics shares closed at $177.57 on Monday. See how other analysts view this stock.
Considering buying NKE stock? Here’s what analysts think:
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.